Follow

Submissions from 2019

PDF

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib., Farrukh T Awan, Anna Schuh, Jennifer R Brown, Richard R Furman, John M Pagel, Peter Hillmen, Deborah M Stephens, Jennifer Woyach, Elena Bibikova, Prista Charuworn, Melanie M Frigault, Ahmed Hamdy, Raquel Izumi, Bolan Linghu, Priti Patel, Min Hui Wang, and John C Byrd

Link

Long-term follow-up of the RESONATE™ phase 3 trial of ibrutinib versus ofatumumab., John C Byrd, Peter Hillmen, Susan O'Brien, Jacqueline C Barrientos, Nishitha M Reddy, Steven Coutre, Constantine S Tam, Stephen P Mulligan, Ulrich Jaeger, Paul M Barr, Richard R Furman, Thomas J Kipps, Patrick Thornton, Carol Moreno, Marco Montillo, John M Pagel, Jan A Burger, Jennifer A Woyach, Sandra Dai, Remus Vezan, Danelle F James, and Jennifer R Brown

Link

Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy., Victor A Chow, Ajay K Gopal, David G Maloney, Cameron J Turtle, Stephen D Smith, Chaitra S Ujjani, Mazyar Shadman, Ryan D Cassaday, Brian G Till, Yolanda D Tseng, Edus H Warren, Andrei R Shustov, Manoj P Menon, Sandra Bhark, Utkarsh H Acharya, Erin Mullane, Lindsay M Hannan, Jenna M Voutsinas, Ted A Gooley, and Ryan C Lynch

Link

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation., Jeffrey A Cohen, Laura E Baldassari, Harold L Atkins, J D Bowen, Christopher Bredeson, Paul A Carpenter, John R Corboy, Mark S Freedman, Linda M Griffith, Robert Lowsky, Navneet S Majhail, Paolo A Muraro, Richard A Nash, Marcelo C Pasquini, Stefanie Sarantopoulos, Bipin N Savani, Jan Storek, Keith M Sullivan, and George E Georges

Link

Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia., Livia Hegerova, Fiona He, Nicole D Zantek, Gregory M Vercellotti, Shernan G Holtan, and Mark T Reding

Link

Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor., Henry P Igid, Kyaw Z Thein, Michael Castine, and Donald P Quick

Link

Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data., Vera Ignjatovic, Philipp E Geyer, Krishnan K Palaniappan, Jessica E Chaaban, Gilbert S Omenn, Mark S Baker, Eric W Deutsch, and Jochen M Schwenk

Link

Granulocyte Colony-Stimulating Factors in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia., Henry G Kaplan, Judith A Malmgren, and Gregory S Calip

Link

ACG Clinical Guideline: Hereditary Hemochromatosis., Kris V Kowdley, Kyle E Brown, Joseph Ahn, and Vinay Sundaram

Link

Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma., Donald J Lucas, Jeremy Rubinstein, Ankush Gosain, Greg Tiao, Tim Head, J Nick Pratap, Regan Williams, Sara Helmig, James Geller, Max Langham, and Angela Trobaugh-Lotrario

Link

A Phase Ib study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma., Joseph Mikhael, Paul Richardson, Saad Z Usmani, Noopur Raje, William Bensinger, Chatchada Karanes, Frank Campana, Dheepak Kanagavel, Franck Dubin, Qianying Liu, Dorothée Semiond, and Kenneth Anderson

Link

Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review., Vincent A Pallazola, Rishi K Kapoor, Karan Kapoor, John W McEvoy, Roger S Blumenthal, and Ty J Gluckman

Link

Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia., Krish Patel and John M Pagel

Link

Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees., Krish Patel, Vinjamuri S Sudhir, Shaum Kabadi, Joanna C Huang, Sanchita Porwal, Kushan Thakkar, and John M Pagel

Link

Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms., Jen-Chin Wang, Chi Chen, Ajay Kundra, Sreenath Kodali, Anita Pandey, Ching Wong, Tony Cheung, Vladimir Gotlieb, Gardith Joseph, and Sophia Tribie

Link

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study., Habte Yimer, Jason Melear, Edward Faber, William Bensinger, John M Burke, Mohit Narang, Don Stevens, Sriya Gunawardena, Yana Lutska, Keqin Qi, Jon Ukropec, Ming Qi, Thomas S Lin, and Robert M Rifkin

Link

Blood Is a Window into Health and Disease., James T Yurkovich and Leroy Hood

Submissions from 2018

Link

Physical activity and epigenetic biomarkers in maternal blood during pregnancy., Sylvia E Badon, Alyson J Littman, Kwun Chuen Gary Chan, Mahlet G Tadesse, Patricia L Stapleton, Theo K Bammler, Tanya K Sorensen, Michelle A Williams, and Daniel A Enquobahrie

PDF

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)., John C Byrd, Amy S Ruppert, Nyla A Heerema, Alese E Halvorson, Eva Hoke, Mitchell R Smith, John E Godwin, Stephen Couban, Todd A Fehniger, Michael J Thirman, Martin S Tallman, Frederick R Appelbaum, Richard M Stone, Sue Robinson, Julie E Chang, Sumithra J Mandrekar, and Richard A Larson

Link

Editorial Perspective., Jens R Chapman

Link

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms, Chi Chen, Anita Pandey, Ajay Kundra, Sreenath Kodali, Ching Wong, Tony W. Cheung, Vladimir K. Gotlieb, Gardith Joseph, Sophia Tribie, and Jen-Chin Wang

Link

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation., Livia Hegerova, Adam Bachan, Qing Cao, Huong X Vu, John Rogosheske, Mark T Reding, Claudio G Brunstein, Mukta Arora, Celalettin Ustun, Gregory M Vercellotti, and Veronika Bachanova

Link

Mindfulness-Based Interventions for Hematology and Oncology Patients with Pain., Denise Hess

Link

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial., Anthony R Mato, Lindsey E Roeker, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Constantine S Tam, Sasanka Handunnetti, Ryan Jacobs, Frederick Lansigan, Erica Bhavsar, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Andre Goy, Douglas F Beach, Jakub Svoboda, Jeffrey J Pu, Alison R Sehgal, Clive S Zent, Hande H Tuncer, Stephen J Schuster, Peter V Pickens, Nirav N Shah, Joanna Rhodes, Chaitra S Ujjani, and Chadi Nabhan

Link

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials., Megan Othus, Elihu H Estey, Guillermo Garcia-Manero, Brent L Wood, Derek L Stirewalt, John E Godwin, James K Weick, Jeanne E Anderson, Frederick R Appelbaum, Harry P Erba, and Roland B Walter

Submissions from 2017

PDF

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease., John C Kash, Kathie-Anne Walters, Jason Kindrachuk, David Baxter, Kelsey Scherler, Krisztina B Janosko, Rick D Adams, Andrew S Herbert, Rebekah M James, Spencer W Stonier, Matthew J Memoli, John M Dye, Richard T Davey, Daniel S Chertow, and Jeffery K Taubenberger

PDF

A Journey of Educational Transformation and Organizational Improvement through Development of an Institutional Patient Blood Management Program, Robert Raggi, Karen Klein, Marci Swearingen, and Mark Domantay

Submissions from 2016

Link

Navigating your career path in pediatric hematology/oncology: On and off the beaten track., Patrick A Zweidler-McKay, Mary-Jane Staba Hogan, Rima Jubran, Vandy Black, Jacqueline Casillas, James Harper, Suman Malempati, Judith Margolin, Judy Felgenhauer, Kathleen M Sakamoto, Janet Franklin, Mona Shah, Nita Seibel, George Buchanan, Sarah R Vaiselbuh, Caroline Hastings, Joanne Hilden, and Linda C Stork